Intersting article, thanks Eqz. No doubt AI can help assist prediction of DKD/CKD in patients looking at retrospective data.
It’s not a clinical test & it is not looking at individual variations, it can’t replace a Dr/patient relationship or predictive value up to 4 years prior (in that individual patient), diagnosis & disease progression on the basis of pathology tests/clinical signs in individuals. We know that this is where PromarkerD will be a very useful test.
AI could be very useful in data collection & analysis of mass populations in order to target health funding & programmes to prevent/treat CKD/DKD, so a useful tool in population/public health. That’s just IMO.
Intersting article, thanks Eqz. No doubt AI can help assist...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.050(4.67%) |
Mkt cap ! $133.6M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.12 | $1.02 | $401.2K | 373.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1130 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 8870 | 1 |
View Market Depth
| Last trade - 15.45pm 11/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |